UK markets closed

Amgen Inc. (AMGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
285.44-0.86 (-0.30%)
As of 01:25PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close286.30
Open287.84
Bid285.30 x 100
Ask285.68 x 100
Day's range285.15 - 288.54
52-week range211.71 - 329.72
Volume666,613
Avg. volume3,032,721
Market cap152.973B
Beta (5Y monthly)0.58
PE ratio (TTM)22.87
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield9.00 (3.14%)
Ex-dividend date16 May 2024
1y target estN/A
  • PR Newswire

    AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) AT AAD 2024

    Amgen (NASDAQ:AMGN) today announced new, 52-week results from the Phase 3 SPROUT study examining the use of Otezla® (apremilast) in children and adolescents aged 6 to 17 years with moderate to severe plaque psoriasis. These data, along with findings from a Phase 3 late-breaking study on Otezla in palmoplantar pustulosis, will be presented at the 2024 American Academy of Dermatology (AAD) Annual Meeting, March 8-12 in San Diego.

  • PR Newswire

    AMGEN ANNOUNCES 2024 SECOND QUARTER DIVIDEND

    Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.25 per share dividend for the second quarter of 2024. The dividend will be paid on June 7, 2024, to all stockholders of record as of the close of business on May 17, 2024.

  • PR Newswire

    AMGEN TO PRESENT AT THE 44TH ANNUAL TD COWEN HEALTH CARE CONFERENCE

    Amgen (NASDAQ:AMGN) will present at the 44th Annual TD Cowen Health Care Conference at 9:10 a.m. ET on Tuesday, March 5, 2024. Peter Griffith, executive vice president and chief financial officer at Amgen, and Paul Burton, senior vice president and chief medical officer at Amgen, will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.